-
公开(公告)号:EP4238556A1
公开(公告)日:2023-09-06
申请号:EP21885314.1
申请日:2021-10-29
申请人: Triastek, Inc.
发明人: DENG, Feihuang , ZHENG, Yu , YAO, Juan , LI, Xiaoling , CHENG, Senping , ZUO, Xianghao
摘要: A pharmaceutical dosage form, comprising: a pharmaceutical unit which includes a medicament, at least one unfolding member, and a retaining member, wherein the unfolding member is connected to the pharmaceutical unit, and is constructed to have a contracted shape, which makes the unfolding member become closer to the pharmaceutical unit, and an unfolding shape, which makes the unfolding member become farther away from the pharmaceutical unit; the retaining member is connected to the at least one unfolding member, and applies a constraint force to the at least one unfolding member, so as to make the unfolding member be in the contracted shape; and the retaining member contains a water-soluble material, and is constructed to remove the constraint force from the unfolding member when the water-soluble material is dissolved, such that the at least one unfolding member can change from the contracted shape to the unfolding shape.
-
公开(公告)号:EP4236924A1
公开(公告)日:2023-09-06
申请号:EP21885357.0
申请日:2021-11-01
申请人: Triastek, Inc.
发明人: DENG, Feihuang , ZHENG, Yu , LI, Xiaoling , CHENG, Senping
-
3.
公开(公告)号:EP4025195A1
公开(公告)日:2022-07-13
申请号:EP20859743.5
申请日:2020-07-08
申请人: Triastek, Inc.
发明人: DENG, Feihuang , LIU, Xin , ZHENG, Yu , CHENG, Jie , CHENG, Senping , LI, Xiaoling
-
4.
公开(公告)号:EP4259107A1
公开(公告)日:2023-10-18
申请号:EP21902632.5
申请日:2021-12-08
申请人: Triastek, Inc.
发明人: DENG, Feihuang , ZHENG, Yu , LIU, Xin , LUO, Qing , CHENG, Jie , WANG, Luo , CHENG, Senping , LI, Xiaoling
IPC分类号: A61K9/20 , A61K9/24 , A61K31/519 , A61P19/00
-
-
-